or Try an Advanced Search...

    Technical Analysis for TTI - Thiogenesis Therapeutics, Corp

    Grade Last Price % Change Price Change
    F 0.600 0.00% 0.000
    TTI closed unchanged on Wednesday, October 30, 2024, on 25 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: Nov 15
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical TTI trend table...
    Date Alert Name Type % Chg
    Boomer Sell Setup Bearish Swing Setup 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Jack-in-the-Box Bearish Bearish Swing Setup -1.64%
    Narrow Range Bar Range Contraction -1.64%
    Older End-of-Day Signals for TTI ...

       Recent Intraday Alerts

    Alert Time
    3x Volume Pace 4 days ago
    2x Volume Pace 4 days ago
    1.5x Volume Pace 4 days ago
    Down 2 ATRs 10 days ago
    Down 1 ATR 10 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    TTI Chart by TradingView
    Basic chart:

    Profile

    Thiogenesis Therapeutics, Corp., a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of a range of unmet genetic and central nervous system diseases. Its lead product candidate under development is TTI-0102, a prodrug consisting of cysteamine and pantetheine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke. The company is headquartered in Toronto, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Stroke

    Is TTI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.06
    52 Week Low 0.59
    Average Volume 19,621
    200-Day Moving Average 0.748
    50-Day Moving Average 0.697
    20-Day Moving Average 0.650
    10-Day Moving Average 0.623
    Average True Range 0.022
    RSI (14) 38.65
    ADX 41.24
    +DI 16.834
    -DI 49.822
    Chandelier Exit (Long, 3 ATRs) 0.653
    Chandelier Exit (Short, 3 ATRs) 0.657
    Upper Bollinger Bands 0.723
    Lower Bollinger Band 0.576
    Percent B (%b) 0.16
    BandWidth 22.510
    MACD Line -0.027
    MACD Signal Line -0.023
    MACD Histogram -0.0042
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.600
    Resistance 3 (R3) 0.600 0.600 0.600
    Resistance 2 (R2) 0.600 0.600 0.600 0.600
    Resistance 1 (R1) 0.600 0.600 0.600 0.600 0.600
    Pivot Point 0.600 0.600 0.600 0.600 0.600
    Support 1 (S1) 0.600 0.600 0.600 0.600 0.600
    Support 2 (S2) 0.600 0.600 0.600 0.600
    Support 3 (S3) 0.600 0.600 0.600
    Support 4 (S4) 0.600